title: Requirement for CD28 in Effector Regulatory T Cell Differentiation, CCR6 Induction, and Skin Homing.
abstract: The skin, similar to most nonlymphoid tissues, contains substantial numbers of T cells. Among these, memory T cells serve a sentinel role to protect against pathogens, and regulatory T cells (Tregs) terminate immune responses as a check against unrestrained inflammation. Previously, we created conditional knockout mice with Treg-specific deletion of CD28. Although these mice have normal numbers of Tregs, these cells have lower levels of CTLA-4, PD-1, and CCR6, and the animals develop systemic autoimmunity characterized by prominent skin inflammation. In this study, we have performed a detailed analysis of the skin disease in these mice. Our data show that Treg-expressed CD28 is required for optimal maturation of CD44(lo)CD62L(hi) central Tregs into CD44(hi)CD62L(lo) effector Tregs (eTregs), as well as induction of CCR6 among the cells that do become eTregs. Although CD28-deficient Tregs are able to regulate inflammation normally when injected directly into the skin, they fail to home properly to inflamed skin. Collectively, these results suggest a key role for CD28 costimulation in promoting a central Treg to eTreg transition with appropriate upregulation of chemokine receptors such as CCR6 that are required for tissue homing.
authors.affiliation: Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA 02129;
authors.forename: Ruan
authors.initials: R
authors.lastname: Zhang
authors.affiliation: Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA 02129; Division of Medical Sciences, Harvard Medical School, Boston, MA 02115; and.
authors.forename: Christopher M
authors.initials: CM
authors.lastname: Borges
authors.affiliation: Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA 02129; Division of Medical Sciences, Harvard Medical School, Boston, MA 02115; and.
authors.forename: Martin Y
authors.initials: MY
authors.lastname: Fan
authors.affiliation: Division of Dermatology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605.
authors.forename: John E
authors.initials: JE
authors.lastname: Harris
authors.affiliation: Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital, Boston, MA 02129; Division of Medical Sciences, Harvard Medical School, Boston, MA 02115; and lturka@partners.org.
authors.forename: Laurence A
authors.initials: LA
authors.lastname: Turka
mesh_terms: D000818:Animals; D018106:CD28 Antigens / Q000502:physiology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D002454:Cell Differentiation; D002465:Cell Movement; D051379:Mice; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000032:analysis; D054399:Receptors, CCR6 / Q000502:physiology*; D012867:Skin / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000166:cytology*
chemical_list: C498126:CCR6 protein, mouse; D018106:CD28 Antigens; D016693:Receptors, Antigen, T-Cell, alpha-beta; D054399:Receptors, CCR6